Skip to main content
Log in

Validity of self-report in identifying anabolic steroid use among weightlifters

  • Brief Reports
  • Published:
Journal of General Internal Medicine Aims and scope Submit manuscript

Abstract

To determine the validity of self-report in the detection of anabolic steroid use among weightlifters, self-report was compared with assay results of simultaneous urine samples from 48 male weightlifters. The sensitivity of self-report in the detection of urinary anabolic steroids was 74%, and specificity was 82%. In addition, 22 of 23 participants who declared current use had at least one undeclared anabolic steroid identified in their urine. However, 15 participants reported at least one drug that was not detected in the urine. Furthermore, 3 of 17 declared nonusers had objective evidence of steroids in their urine. The validity of self-report may be inadequate to differentiate reliably between users and nonusers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. DuRant RH, Rickert VI, Ashworth CS, Newman C, Slavens G. Use of multiple drugs among adolescents who use anabolic steroids. N Engl J Med. 1993;328:922–6.

    Article  PubMed  CAS  Google Scholar 

  2. Yesalis CE, Kennedy NJ, Kopstein AN, Bahrke MS. Anabolic-androgenic steroid use in the United States. JAMA. 1993;270:1217–21.

    Article  PubMed  CAS  Google Scholar 

  3. Anderson WA, Albrecht RR, McKeag DB. Second replication of a national survey of the substance use and abuse habits of college student athletes. Final report presented to National Collegiate Athletics Association, Overland Park, Kan, July 1993.

  4. Haupt HA. Anabolic steroids and growth hormone. Am J Sports Med. 1993;21:468–73.

    PubMed  CAS  Google Scholar 

  5. Lanas A, Sekar MC, Hirschowitz BI. Objective evidence of aspirin use in both ulcer and nonulcer upper and lower gastrointestinal bleeding. Gastroenterology. 1992;103:862–9.

    PubMed  CAS  Google Scholar 

  6. Sherman MF, Bigelow GE. Validity of patients’ self-reported drug use as a function of treatment status. Drug Alcohol Depend. 1992;30:1–11.

    Article  PubMed  CAS  Google Scholar 

  7. McNagny SE, Parker RM. High prevalence of recent cocaine use and the unreliability of patient self-report in an inner-city walk-in clinic. JAMA. 1991;267:1106–8.

    Article  Google Scholar 

  8. Ferenchick GS, Hirokawa S, Mammen EF, Schwartz KS. Anabolic-androgenic steroid abuse in weightlifters: evidence for activation of the hemostatic system. Am J Hematol. 1995;49:282–8.

    Article  PubMed  CAS  Google Scholar 

  9. Narducci WA, Wagner JC, Hendrickson TP, Jeffrey TP. Anabolic steroids—a review of the clinical toxicology and diagnostic screening. Clin Toxicol. 1990;28:287–310.

    CAS  Google Scholar 

  10. Ansell JE, Tiarks C, Fairchild VK. Coagulation abnormalities associated with the use of anabolic steroids. Am Heart J. 1993;125:367–71.

    Article  PubMed  CAS  Google Scholar 

  11. Bahrke MS, Wright JE, Strauss RH, Catlin DH. Psychological moods and subjectively perceived behavioral and somatic changes accompanying anabolic-androgenic steroid use. Am J Sports Med. 1992;20:717–24.

    PubMed  CAS  Google Scholar 

  12. Cohen JC, Noakes TD, Benade AJS. Hypercholesterolemia in male power lifters using anabolic-androgenic steroids. Physician Sports-med. 1988;16:49–56.

    Google Scholar 

  13. DePiccoli B, Giada F, Benettin A, Sartori F, Piccolo E. Anabolic steroid use in body builders: an echocardiographic study of left ventricle morphology and function. Int J Sports Med. 1991;12:408–12.

    CAS  Google Scholar 

  14. Frohlich J, Kullmer T, Urhausen A, Bergmann R, Kindermann W. Lipid profile of body builders with and without self-administration of anabolic steroids. Eur J Appl Physiol. 1989;59:98–103.

    Article  CAS  Google Scholar 

  15. Hakkinen K, Alen M. Training volume, androgen use and serum creatine kinase activity. Br J Sports Med. 1989;23:188–9.

    PubMed  CAS  Google Scholar 

  16. McKillop G, Ballantyne FC, Borland W, Dip CB, Ballantyne D. Acute metabolic effects of exercise in body builders using anabolic steroids. Br J Sports Med. 1989;23:186–7.

    PubMed  CAS  Google Scholar 

  17. Moffatt RJ, Wallace MB, Sady SP. Effects of anabolic steroids on lipoprotein profiles of female weight lifters. Physician Sportsmed. 1990;18:106–15.

    Google Scholar 

  18. Moss HB, Panzak GL, Tarter RE. Sexual functioning of male anabolic steroid abusers. Arch Sex Behav. 1993;22:1–12.

    Article  PubMed  CAS  Google Scholar 

  19. Urhausen A, Holpes R, Kindermann W. One- and two-dimensional echocardiography in bodybuilders using anabolic steroids. Eur J Appl Physiol. 1989;58:633–40.

    Article  CAS  Google Scholar 

  20. Zuliani U, Bernardini B, Catapano A, Campana M, Cerioli G, Spattini M. Effects of anabolic steroids, testosterone, and HGH on blood lipids and echocardiographic parameters in body builders. Int J Sports Med. 1988;10:62–6.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Received from the Department of Medicine, Division of General Internal Medicine, Michigan State University, East Lansing.

Supported in part by a grant from the National Collegiate Athletic Association (NCAA).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ferenchick, G.S. Validity of self-report in identifying anabolic steroid use among weightlifters. J Gen Intern Med 11, 554–556 (1996). https://doi.org/10.1007/BF02599607

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02599607

Key words

Navigation